Ibotta (IBTA) Financials

$32.33 -0.39 (-1.19%)

As of 05/13/2026 03:58 PM Eastern

Annual Income Statements for Ibotta

This table shows Ibotta's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-55	38	69	3.58
Consolidated Net Income / (Loss)	-55	38	69	3.58
Net Income / (Loss) Continuing Operations	-55	38	69	3.58
Total Pre-Tax Income	-55	44	24	9.85
Total Operating Income	-40	56	28	-0.84
Total Gross Profit	165	276	317	271
Total Revenue	211	320	367	342
Operating Revenue	211	320	367	342
Total Cost of Revenue	46	44	50	71
Operating Cost of Revenue	46	44	50	71
Total Operating Expenses	205	220	289	272
Selling, General & Admin Expense	49	52	83	88
Marketing Expense	110	115	139	119
Research & Development Expense	43	50	63	61
Depreciation Expense	3.05	3.66	3.98	3.91
Total Other Income / (Expense), net	-14	-12	-3.43	11
Interest Expense	0.00	0.00	9.69	0.00
Interest & Investment Income	-5.31	-6.88	9.41	11
Other Income / (Expense), net	-8.98	-5.06	-3.16	-0.09
Income Tax Expense	0.26	5.93	-44	6.27
Basic Earnings per Share	($6.33)	$4.26	$2.85	$0.13
Weighted Average Basic Shares Outstanding	8.67M	8.95M	24.12M	28.37M
Diluted Earnings per Share	($6.33)	$1.42	$2.56	$0.12
Weighted Average Diluted Shares Outstanding	8.67M	26.92M	26.86M	30.10M
Weighted Average Basic & Diluted Shares Outstanding	-	-	31.02M	24.35M

This table shows Ibotta's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	8.41	19	9.30	-34	17	76	0.56	2.49	1.53	-1.00	-10
Consolidated Net Income / (Loss)	8.41	19	9.30	-34	17	76	0.56	2.49	1.53	-1.00	-10
Net Income / (Loss) Continuing Operations	8.41	19	9.30	-34	17	76	0.56	2.49	1.53	-1.00	-10
Total Pre-Tax Income	7.80	22	12	-30	25	17	0.48	3.87	5.25	0.24	-9.35
Total Operating Income	11	26	16	-22	21	13	-2.80	1.24	2.37	-1.64	-11
Total Gross Profit	75	87	72	76	86	83	67	68	66	70	63
Total Revenue	85	100	82	88	99	98	85	86	83	89	82
Operating Revenue	85	100	82	88	99	98	85	86	83	89	82
Total Cost of Revenue	11	12	11	12	12	15	17	18	17	19	19
Operating Cost of Revenue	11	12	11	12	12	15	17	18	17	19	19
Total Operating Expenses	64	61	56	97	66	70	70	67	64	71	74
Selling, General & Admin Expense	12	13	13	29	21	20	21	22	22	22	24
Marketing Expense	38	33	28	50	28	33	30	29	27	34	34
Research & Development Expense	12	14	14	18	16	16	18	15	14	14	15
Depreciation Expense	1.50	0.65	0.98	1.05	1.07	0.89	0.97	1.05	0.64	1.26	1.56
Total Other Income / (Expense), net	-3.07	-3.92	-3.51	-8.37	4.42	4.03	3.29	2.63	2.89	1.89	1.48
Interest & Investment Income	-1.56	-2.11	-1.81	2.67	4.44	4.11	3.69	2.64	2.51	1.95	1.51
Other Income / (Expense), net	-1.51	-1.81	-1.70	-1.41	-0.02	-0.03	-0.40	-0.01	0.38	-0.06	-0.03
Income Tax Expense	-0.61	3.69	3.10	3.94	7.89	-59	-0.07	1.38	3.72	1.25	0.97
Basic Earnings per Share	$0.94	$2.08	$1.00	($1.32)	$0.56	$2.61	$0.02	$0.09	$0.05	($0.03)	($0.43)
Weighted Average Basic Shares Outstanding	8.96M	8.95M	9.31M	25.66M	30.66M	24.12M	30.78M	28.48M	28.00M	28.37M	24.15M
Diluted Earnings per Share	$0.31	$1.02	$0.33	($1.32)	$0.51	$3.04	$0.02	$0.08	$0.05	($0.03)	($0.43)
Weighted Average Diluted Shares Outstanding	26.83M	26.92M	28.36M	25.66M	33.57M	26.86M	33.22M	30.43M	29.38M	30.10M	24.15M
Weighted Average Basic & Diluted Shares Outstanding	-	0.00	30.45M	30.64M	30.63M	31.02M	28.45M	28.40M	26.58M	24.35M	23.27M

This table details how cash moves in and out of Ibotta's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-18	45	287	-163
Net Cash From Operating Activities	-56	23	116	95
Net Cash From Continuing Operating Activities	-56	23	116	95
Net Income / (Loss) Continuing Operations	-55	38	69	3.58
Consolidated Net Income / (Loss)	-55	38	69	3.58
Depreciation Expense	6.32	6.66	8.08	8.32
Amortization Expense	2.57	3.31	1.06	0.15
Non-Cash Adjustments To Reconcile Net Income	29	87	112	69
Changes in Operating Assets and Liabilities, net	-39	-112	-74	14
Net Cash From Investing Activities	-36	20	-10	-34
Net Cash From Continuing Investing Activities	-36	20	-10	-34
Purchase of Property, Plant & Equipment	-8.26	-8.23	-10	-34
Sale and/or Maturity of Investments	39	28	0.00	0.00
Net Cash From Financing Activities	74	2.39	181	-224
Net Cash From Continuing Financing Activities	74	2.39	181	-224
Repayment of Debt	-5.57	-0.01	-0.90	-0.00
Repurchase of Common Equity	-0.03	-0.65	-37	-233
Issuance of Common Equity	0.00	0.00	209	3.22
Other Financing Activities, net	1.14	3.05	10	5.70
Cash Interest Paid	3.52	5.49	2.58	0.25
Cash Income Taxes Paid	0.07	4.11	13	5.15

This table details how cash moves in and out of Ibotta's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-4.03	23	17	238	23	8.42	-52	-47	-27	-37	-22
Net Cash From Operating Activities	-2.02	24	19	35	40	22	20	26	22	28	30
Net Cash From Continuing Operating Activities	-2.02	24	19	35	40	22	20	26	22	28	30
Net Income / (Loss) Continuing Operations	8.41	19	9.30	-34	17	76	0.56	2.49	1.53	-1.00	-10
Consolidated Net Income / (Loss)	8.41	19	9.30	-34	17	76	0.56	2.49	1.53	-1.00	-10
Depreciation Expense	2.50	0.92	1.91	2.11	2.14	1.92	2.17	2.45	1.24	2.47	2.87
Amortization Expense	0.83	0.84	0.83	0.20	0.01	0.02	0.04	0.04	0.04	0.04	0.04
Non-Cash Adjustments To Reconcile Net Income	27	43	1.09	70	30	11	6.88	23	17	22	16
Changes in Operating Assets and Liabilities, net	-40	-39	6.25	-3.06	-9.92	-67	10	-2.05	1.85	4.21	21
Net Cash From Investing Activities	-2.48	-1.99	-2.47	-2.32	-2.87	-2.55	-4.97	-7.00	-11	-11	-7.06
Net Cash From Continuing Investing Activities	-2.48	-1.99	-2.47	-2.32	-2.87	-2.55	-4.97	-7.00	-11	-11	-7.06
Purchase of Property, Plant & Equipment	-2.48	-1.99	-2.47	-2.32	-2.87	-2.55	-4.97	-7.00	-11	-11	-7.09
Sale of Property, Plant & Equipment	-	-	-	-	-	-	0.00	-	-	-	0.03
Net Cash From Financing Activities	0.48	1.24	0.01	206	-13	-11	-67	-66	-38	-53	-45
Net Cash From Continuing Financing Activities	0.48	1.24	0.01	206	-13	-11	-67	-66	-38	-53	-45
Repayment of Debt	-	-0.01	-0.09	-0.00	-0.01	-0.80	-0.00	-	-	-	0.00
Repurchase of Common Equity	-0.00	-0.65	-1.70	-3.94	-16	-16	-70	-70	-38	-55	-45
Other Financing Activities, net	0.48	1.90	1.80	2.91	2.70	2.76	2.73	2.58	0.16	0.24	-0.50
Cash Interest Paid	1.17	2.03	1.99	-	0.03	0.05	0.02	0.08	0.08	0.08	0.08
Cash Income Taxes Paid	1.35	2.21	-	-	3.17	5.07	0.00	-	0.24	0.81	0.57

This table presents Ibotta's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	12/31/2023	12/31/2024	12/31/2025
Total Assets	320	678	526
Total Current Assets	298	582	408
Cash & Equivalents	63	349	187
Accounts Receivable	226	221	209
Prepaid Expenses	9.31	11	13
Plant, Property, & Equipment, net	2.54	1.95	23
Total Noncurrent Assets	19	95	95
Intangible Assets	13	16	24
Noncurrent Deferred & Refundable Income Taxes	0.00	73	55
Other Noncurrent Operating Assets	6.06	5.33	16
Total Liabilities & Shareholders' Equity	320	678	526
Total Liabilities	292	221	238
Total Current Liabilities	198	204	208
Accounts Payable	8.94	7.16	11
Accrued Expenses	25	18	20
Current Deferred Revenue	87	79	68
Other Current Liabilities	77	100	109
Total Noncurrent Liabilities	94	17	31
Other Noncurrent Operating Liabilities	29	17	31
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	28	457	288
Total Preferred & Common Equity	28	457	288
Preferred Stock	0.00	0.00	0.00
Total Common Equity	28	457	288
Common Stock	237	629	692
Retained Earnings	-209	-140	-137
Other Equity Adjustments	-	-	-268

This table presents Ibotta's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	322	556	598	639	601	569	480
Total Current Assets	300	534	576	528	483	455	361
Cash & Equivalents	79	318	341	297	251	223	165
Accounts Receivable	206	209	228	206	209	213	183
Prepaid Expenses	14	7.35	6.99	24	23	19	13
Plant, Property, & Equipment, net	2.39	2.27	2.06	4.44	9.04	20	23
Total Noncurrent Assets	20	20	20	107	109	94	96
Intangible Assets	14	14	15	18	19	22	26
Noncurrent Deferred & Refundable Income Taxes	-	-	-	73	74	56	54
Other Noncurrent Operating Assets	5.64	5.18	4.71	16	16	16	15
Total Liabilities & Shareholders' Equity	322	556	598	639	601	569	480
Total Liabilities	278	196	220	238	247	240	231
Total Current Liabilities	182	190	211	197	204	207	201
Accounts Payable	7.68	5.24	8.25	11	11	15	7.24
Accrued Expenses	15	17	19	15	18	17	20
Current Deferred Revenue	87	84	85	78	76	74	66
Other Current Liabilities	71	84	100	92	100	100	108
Total Noncurrent Liabilities	96	6.18	8.84	41	43	33	30
Other Noncurrent Operating Liabilities	31	6.18	8.84	25	25	25	30
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	44	360	378	401	354	330	249
Total Preferred & Common Equity	44	360	378	401	354	330	249
Preferred Stock	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	44	360	378	401	354	330	249
Common Stock	244	594	610	646	664	678	709
Retained Earnings	-200	-234	-217	-140	-137	-136	-147
Other Equity Adjustments	-	-	-	-	-	-	-313

This table displays calculated financial ratios and metrics derived from Ibotta's official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	51.89%	14.75%	-6.77%
EBITDA Growth	0.00%	250.76%	-44.34%	-77.77%
EBIT Growth	0.00%	203.34%	-51.37%	-103.77%
NOPAT Growth	0.00%	271.71%	61.72%	-100.39%
Net Income Growth	0.00%	169.48%	80.34%	-94.80%
EPS Growth	0.00%	122.43%	80.28%	-95.31%
Operating Cash Flow Growth	0.00%	140.21%	410.29%	-17.81%
Free Cash Flow Firm Growth	0.00%	0.00%	-97.02%	1,022.56%
Invested Capital Growth	0.00%	0.00%	261.23%	-6.09%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	-2.80%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	-65.14%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-106.81%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-100.73%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-95.57%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-96.24%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	6.50%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	122.50%
Invested Capital Q/Q Growth	0.00%	0.00%	193.30%	-4.91%
Profitability Metrics	-	-	-	-
Gross Margin	78.08%	86.25%	86.35%	79.25%
EBITDA Margin	-19.17%	19.03%	9.23%	2.20%
Operating Margin	-19.13%	17.50%	7.60%	-0.25%
EBIT Margin	-23.39%	15.92%	6.74%	-0.27%
Profit (Net Income) Margin	-26.04%	11.91%	18.72%	1.04%
Tax Burden Percent	100.48%	86.53%	280.63%	36.31%
Interest Burden Percent	110.78%	86.48%	98.90%	-1,054.28%
Effective Tax Rate	0.00%	13.47%	-180.63%	63.69%
Return on Invested Capital (ROIC)	0.00%	325.37%	114.09%	-0.29%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-788.10%	119.62%	-1.74%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-52.40%	-85.75%	1.25%
Return on Equity (ROE)	0.00%	272.97%	28.33%	0.96%
Cash Return on Invested Capital (CROIC)	0.00%	125.37%	0.81%	5.99%
Operating Return on Assets (OROA)	0.00%	15.93%	4.96%	-0.16%
Return on Assets (ROA)	0.00%	11.92%	13.77%	0.59%
Return on Common Equity (ROCE)	0.00%	272.97%	28.33%	0.96%
Return on Equity Simple (ROE_SIMPLE)	0.00%	136.48%	15.03%	0.00%
Net Operating Profit after Tax (NOPAT)	-28	48	78	-0.31
NOPAT Margin	-13.39%	15.14%	21.34%	-0.09%
Net Nonoperating Expense Percent (NNEP)	0.00%	1,113.46%	-5.53%	1.45%
Return On Investment Capital (ROIC_SIMPLE)	-	52.45%	17.14%	-0.11%
Cost of Revenue to Revenue	21.92%	13.75%	13.65%	20.75%
SG&A Expenses to Revenue	23.33%	16.13%	22.53%	25.77%
R&D to Revenue	20.20%	15.62%	17.23%	17.84%
Operating Expenses to Revenue	97.22%	68.76%	78.75%	79.49%
Earnings before Interest and Taxes (EBIT)	-49	51	25	-0.93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-40	61	34	7.54
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	20.67	4.36	2.10
Price to Tangible Book Value (P/TBV)	0.00	38.28	4.52	2.29
Price to Revenue (P/Rev)	2.74	1.80	5.43	1.76
Price to Earnings (P/E)	0.00	15.15	29.00	169.01
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	6.60%	3.45%	0.59%
Enterprise Value to Invested Capital (EV/IC)	0.00	19.45	15.28	4.13
Enterprise Value to Revenue (EV/Rev)	0.00	1.81	4.48	1.22
Enterprise Value to EBITDA (EV/EBITDA)	0.00	9.51	48.48	55.40
Enterprise Value to EBIT (EV/EBIT)	0.00	11.37	66.36	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	11.95	20.97	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	25.50	14.18	4.38
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	31.02	2,952.61	66.83
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	2.31	0.00	0.00
Long-Term Debt to Equity	0.00	2.31	0.00	0.00
Financial Leverage	0.00	0.07	-0.72	-0.72
Leverage Ratio	0.00	11.45	2.06	1.62
Compound Leverage Factor	0.00	9.90	2.03	-17.04
Debt to Total Capital	0.00%	69.77%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	69.77%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	30.23%	100.00%	100.00%
Debt to EBITDA	0.00	1.06	0.00	0.00
Net Debt to EBITDA	0.00	0.03	0.00	0.00
Long-Term Debt to EBITDA	0.00	1.06	0.00	0.00
Debt to NOPAT	0.00	1.33	0.00	0.00
Net Debt to NOPAT	0.00	0.04	0.00	0.00
Long-Term Debt to NOPAT	0.00	1.33	0.00	0.00
Altman Z-Score	0.00	2.17	6.45	2.26
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	1.51	2.85	1.96
Quick Ratio	0.00	1.46	2.79	1.90
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	19	0.56	6.25
Operating Cash Flow to CapEx	-683.76%	276.08%	1,136.33%	277.74%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.06	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	11.97	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	10.91	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	1.00	0.74	0.57
Accounts Receivable Turnover	0.00	1.41	1.64	1.59
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	125.95	163.51	26.98
Accounts Payable Turnover	0.00	4.92	6.23	7.90
Days Sales Outstanding (DSO)	0.00	258.25	222.29	228.98
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	74.15	58.61	46.23
Cash Conversion Cycle (CCC)	0.00	184.10	163.68	182.75
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	30	108	101
Invested Capital Turnover	0.00	21.49	5.35	3.28
Increase / (Decrease) in Invested Capital	0.00	30	78	-6.55
Enterprise Value (EV)	0.00	579	1,644	418
Market Capitalization	577	577	1,993	604
Book Value per Share	$0.00	$3.12	$14.93	$10.82
Tangible Book Value per Share	$0.00	$1.69	$14.40	$9.91
Total Capital	0.00	92	457	288
Total Debt	0.00	64	0.00	0.00
Total Long-Term Debt	0.00	64	0.00	0.00
Net Debt	0.00	1.86	-350	-187
Capital Expenditures (CapEx)	8.26	8.23	10	34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	38	28	14
Debt-free Net Working Capital (DFNWC)	0.00	100	378	200
Net Working Capital (NWC)	0.00	100	378	200
Net Nonoperating Expense (NNE)	27	10	9.62	-3.88
Net Nonoperating Obligations (NNO)	0.00	1.86	-350	-187
Total Depreciation and Amortization (D&A)	8.89	9.97	9.14	8.47
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	11.75%	7.59%	3.96%
Debt-free Net Working Capital to Revenue	0.00%	31.31%	102.81%	58.46%
Net Working Capital to Revenue	0.00%	31.31%	102.81%	58.46%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$2.85	$0.13
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	24.12M	28.37M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$2.56	$0.12
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	26.86M	30.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	31.02M	24.35M
Normalized Net Operating Profit after Tax (NOPAT)	-28	48	20	-0.59
Normalized NOPAT Margin	-13.39%	15.14%	5.32%	-0.17%
Pre Tax Income Margin	-25.91%	13.76%	6.67%	2.88%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	2.56	0.00
NOPAT to Interest Expense	0.00	0.00	8.09	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	1.50	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	7.04	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.05%	1.71%	54.35%	6,516.67%

This table displays calculated financial ratios and metrics derived from Ibotta's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	31,022,388.00	28,447,773.00	28,398,786.00	-	24,350,180.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	31,022,388.00	28,447,773.00	28,398,786.00	-	24,350,180.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	0.02	0.09	0.05	-	-0.42
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	42.70%	13.62%	15.63%	-1.30%	2.73%	-2.16%	-15.58%	-10.02%	-2.47%
EBITDA Growth	0.00%	0.00%	121,085.71%	-194.17%	79.97%	-43.18%	-105.90%	117.90%	-82.38%	-94.63%	-696.20%
EBIT Growth	0.00%	0.00%	680.90%	-217.85%	121.08%	-47.04%	-122.54%	105.34%	-86.75%	-113.18%	-239.26%
NOPAT Growth	0.00%	0.00%	1,908.74%	-189.93%	21.22%	165.11%	-127.01%	105.26%	-95.14%	-88.39%	-135.42%
Net Income Growth	0.00%	0.00%	317.07%	-321.41%	104.91%	308.52%	-94.03%	107.33%	-91.11%	-101.32%	-1,959.82%
EPS Growth	0.00%	0.00%	167.35%	-327.59%	64.52%	198.04%	-93.94%	106.06%	-90.20%	-100.99%	-2,250.00%
Operating Cash Flow Growth	0.00%	0.00%	619.39%	2,260.39%	2,054.72%	-7.10%	2.55%	-26.17%	-44.99%	26.46%	52.94%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-329.77%	-6.80%	-206.44%	167.55%	115.28%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	261.23%	247.36%	147.40%	189.65%	-6.09%	-18.66%
Revenue Q/Q Growth	10.21%	16.87%	0.00%	6.80%	12.16%	-0.24%	-14.03%	1.72%	-3.22%	6.32%	-6.83%
EBITDA Q/Q Growth	-42.43%	106.45%	0.00%	-222.53%	210.03%	-34.82%	-106.71%	471.77%	8.35%	-80.14%	-1,095.49%
EBIT Q/Q Growth	-52.19%	161.19%	0.00%	-262.44%	189.68%	-37.44%	-124.74%	138.48%	122.56%	-162.22%	-536.75%
NOPAT Q/Q Growth	-30.48%	87.04%	0.00%	-227.11%	193.71%	309.07%	-105.54%	124.74%	-13.34%	877.35%	-212.34%
Net Income Q/Q Growth	-45.16%	121.63%	0.00%	-465.34%	150.75%	341.86%	-99.27%	348.65%	-38.43%	-165.43%	-929.11%
EPS Q/Q Growth	-46.55%	229.03%	0.00%	-500.00%	138.64%	496.08%	-99.34%	300.00%	-37.50%	-160.00%	-1,333.33%
Operating Cash Flow Q/Q Growth	-24.80%	1,269.95%	0.00%	80.83%	12.92%	-44.40%	-9.67%	30.19%	-15.86%	27.82%	9.24%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-217.76%	60.57%	12.39%	-291.49%	21.04%	-13.14%	119.31%	-11.47%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	40.11%	-12.33%	193.30%	-3.58%	-0.21%	2.64%	-4.91%	-16.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	87.36%	87.64%	87.23%	86.03%	87.66%	84.60%	79.79%	79.16%	79.41%	78.65%	76.42%
EBITDA Margin	14.88%	26.28%	20.57%	-23.60%	23.15%	15.13%	-1.18%	4.32%	4.83%	0.90%	-9.64%
Operating Margin	12.75%	26.34%	19.32%	-24.63%	21.00%	13.18%	-3.31%	1.44%	2.84%	-1.85%	-13.13%
EBIT Margin	10.97%	24.53%	17.25%	-26.24%	20.98%	13.16%	-3.79%	1.43%	3.29%	-1.93%	-13.17%
Profit (Net Income) Margin	9.86%	18.71%	11.29%	-38.63%	17.48%	77.43%	0.66%	2.89%	1.84%	-1.13%	-12.51%
Tax Burden Percent	107.82%	83.49%	74.99%	113.11%	68.61%	448.07%	114.91%	64.37%	29.19%	-411.07%	110.36%
Interest Burden Percent	83.37%	91.36%	87.29%	130.16%	121.44%	131.32%	-15.08%	313.96%	191.54%	-14.30%	86.10%
Effective Tax Rate	-7.82%	16.51%	25.01%	0.00%	31.39%	-348.07%	-14.91%	35.63%	70.81%	511.07%	0.00%
Return on Invested Capital (ROIC)	0.00%	236.31%	0.00%	0.00%	0.00%	315.83%	-21.06%	4.69%	4.09%	25.03%	-33.26%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	59.94%	0.00%	0.00%	0.00%	305.45%	-23.49%	4.09%	3.79%	27.92%	-32.07%
Return on Net Nonoperating Assets (RNNOA)	0.00%	3.99%	0.00%	0.00%	0.00%	-218.97%	16.44%	-3.26%	-3.02%	-20.10%	22.79%
Return on Equity (ROE)	0.00%	240.30%	0.00%	0.00%	0.00%	96.87%	-4.62%	1.43%	1.06%	4.93%	-10.46%
Cash Return on Invested Capital (CROIC)	0.00%	62.68%	0.00%	0.00%	0.00%	0.81%	-44.79%	6.83%	-38.86%	5.99%	6,280.29%
Operating Return on Assets (OROA)	0.00%	24.54%	0.00%	0.00%	0.00%	9.68%	-2.91%	0.91%	1.99%	-1.10%	-8.01%
Return on Assets (ROA)	0.00%	18.72%	0.00%	0.00%	0.00%	56.97%	0.50%	1.84%	1.11%	-0.64%	-7.61%
Return on Common Equity (ROCE)	0.00%	240.30%	0.00%	0.00%	0.00%	96.87%	-4.62%	1.43%	1.06%	4.93%	-10.46%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.95%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	12	22	12	-15	14	58	-3.22	0.80	0.69	6.75	-7.58
NOPAT Margin	13.74%	21.99%	14.49%	-17.24%	14.41%	59.07%	-3.81%	0.93%	0.83%	7.62%	-9.19%
Net Nonoperating Expense Percent (NNEP)	0.00%	176.37%	-36.96%	-11.83%	1.78%	10.38%	2.42%	0.60%	0.30%	-2.89%	-1.19%
Return On Investment Capital (ROIC_SIMPLE)	-	23.73%	-	-	-	12.71%	-0.80%	0.23%	0.21%	2.35%	-3.05%
Cost of Revenue to Revenue	12.64%	12.36%	12.77%	13.97%	12.34%	15.40%	20.21%	20.84%	20.59%	21.35%	23.58%
SG&A Expenses to Revenue	14.20%	13.50%	15.98%	32.65%	20.92%	20.58%	25.29%	25.88%	26.98%	25.00%	28.81%
R&D to Revenue	14.53%	13.73%	16.57%	19.93%	16.51%	16.08%	21.36%	17.14%	16.84%	16.09%	17.58%
Operating Expenses to Revenue	74.62%	61.30%	67.91%	110.66%	66.66%	71.42%	83.10%	77.73%	76.57%	80.51%	89.55%
Earnings before Interest and Taxes (EBIT)	9.36	24	14	-23	21	13	-3.20	1.23	2.74	-1.71	-11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	13	26	17	-21	23	15	-1.00	3.71	4.02	0.80	-7.95
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	20.67	13.09	6.36	4.99	4.36	3.26	2.94	2.40	2.10	2.93
Price to Tangible Book Value (P/TBV)	0.00	38.28	19.12	6.63	5.21	4.52	3.41	3.11	2.57	2.29	3.28
Price to Revenue (P/Rev)	0.00	1.80	0.00	0.00	0.00	5.43	3.54	2.83	2.25	1.76	2.14
Price to Earnings (P/E)	0.00	15.15	0.00	0.00	0.00	29.00	21.82	10.79	9.79	169.01	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	6.60%	0.00%	0.00%	0.00%	3.45%	4.58%	9.26%	10.21%	0.59%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	19.45	18.85	47.10	42.16	15.28	9.75	7.64	5.34	4.13	6.70
Enterprise Value to Revenue (EV/Rev)	0.00	1.81	0.00	0.00	0.00	4.48	2.74	2.15	1.61	1.22	1.66
Enterprise Value to EBITDA (EV/EBITDA)	0.00	9.51	0.00	0.00	0.00	48.48	63.36	19.55	26.25	55.40	969.43
Enterprise Value to EBIT (EV/EBIT)	0.00	11.37	0.00	0.00	0.00	66.36	137.39	24.97	41.38	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	11.95	0.00	0.00	0.00	20.97	23.01	11.86	13.58	0.00	0.10
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	25.50	0.00	0.00	0.00	14.18	8.69	7.37	6.34	4.38	5.34
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	2,952.61	0.00	159.23	0.00	66.83	0.10
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	2.31	1.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	2.31	1.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	0.07	-0.32	-0.88	-0.90	-0.72	-0.70	-0.80	-0.80	-0.72	-0.71
Leverage Ratio	0.00	11.45	7.30	1.55	1.58	2.06	2.16	1.62	1.65	1.62	1.72
Compound Leverage Factor	0.00	10.46	6.38	2.01	1.92	2.70	-0.33	5.09	3.16	-0.23	1.48
Debt to Total Capital	0.00%	69.77%	59.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	69.77%	59.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	30.23%	40.32%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	1.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	1.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	1.90	0.96	7.01	5.48	6.39	4.18	3.39	2.80	2.25	2.50
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.51	1.65	2.81	2.72	2.85	2.69	2.37	2.21	1.96	1.80
Quick Ratio	0.00	1.46	1.57	2.77	2.69	2.79	2.56	2.25	2.11	1.90	1.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	-18	-57	-22	-20	-77	-61	-69	13	12
Operating Cash Flow to CapEx	-81.54%	1,192.34%	785.00%	1,508.18%	1,379.28%	863.93%	399.76%	369.36%	194.93%	248.81%	430.17%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-5.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.00	0.00	0.00	0.00	0.74	0.77	0.64	0.60	0.57	0.61
Accounts Receivable Turnover	0.00	1.41	0.00	0.00	0.00	1.64	1.79	1.76	1.60	1.59	1.75
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	125.95	0.00	0.00	0.00	163.51	108.26	64.97	32.56	26.98	24.61
Accounts Payable Turnover	0.00	4.92	0.00	0.00	0.00	6.23	5.98	7.88	5.71	7.90	7.92
Days Sales Outstanding (DSO)	0.00	258.25	0.00	0.00	0.00	222.29	203.78	207.52	228.29	228.98	208.73
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	74.15	0.00	0.00	0.00	58.61	61.09	46.35	63.88	46.23	46.09
Cash Conversion Cycle (CCC)	0.00	184.10	0.00	0.00	0.00	163.68	142.70	161.17	164.40	182.75	162.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	30	30	42	37	108	104	104	106	101	84
Invested Capital Turnover	0.00	10.74	0.00	0.00	0.00	5.35	5.53	5.06	4.93	3.28	3.62
Increase / (Decrease) in Invested Capital	0.00	0.00	30	42	37	78	74	62	70	-6.55	-19
Enterprise Value (EV)	0.00	579	563	1,971	1,546	1,644	1,012	791	568	418	565
Market Capitalization	577	577	577	2,289	1,888	1,993	1,309	1,041	791	604	730
Book Value per Share	$0.00	$3.12	$4.74	$11.81	$12.34	$14.93	$12.94	$12.45	$11.61	$10.82	$10.22
Tangible Book Value per Share	$0.00	$1.69	$3.24	$11.34	$11.83	$14.40	$12.37	$11.78	$10.82	$9.91	$9.14
Total Capital	0.00	92	109	360	378	457	401	354	330	288	249
Total Debt	0.00	64	65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	64	65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	1.86	-14	-318	-341	-350	-298	-251	-223	-187	-165
Capital Expenditures (CapEx)	2.48	1.99	2.47	2.32	2.87	2.55	4.97	7.00	11	11	7.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	38	39	26	23	28	34	28	26	14	-4.52
Debt-free Net Working Capital (DFNWC)	0.00	100	118	344	365	378	331	279	249	200	160
Net Working Capital (NWC)	0.00	100	118	344	365	378	331	279	249	200	160
Net Nonoperating Expense (NNE)	3.31	3.28	2.63	19	-3.03	-18	-3.78	-1.69	-0.84	7.75	2.74
Net Nonoperating Obligations (NNO)	0.00	1.86	-14	-318	-341	-350	-298	-251	-223	-187	-165
Total Depreciation and Amortization (D&A)	3.33	1.75	2.74	2.32	2.14	1.94	2.20	2.48	1.28	2.51	2.91
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	11.75%	0.00%	0.00%	0.00%	7.59%	9.19%	7.62%	7.26%	3.96%	-1.33%
Debt-free Net Working Capital to Revenue	0.00%	31.31%	0.00%	0.00%	0.00%	102.81%	89.71%	75.79%	70.67%	58.46%	47.04%
Net Working Capital to Revenue	0.00%	31.31%	0.00%	0.00%	0.00%	102.81%	89.71%	75.79%	70.67%	58.46%	47.04%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$2.08	$1.00	($1.32)	$0.56	$2.61	$0.02	$0.09	$0.05	($0.03)	($0.43)
Adjusted Weighted Average Basic Shares Outstanding	0.00	8.95M	9.31M	25.66M	30.66M	24.12M	30.78M	28.48M	28.00M	28.37M	24.15M
Adjusted Diluted Earnings per Share	$0.00	$1.02	$0.33	($1.32)	$0.51	$3.04	$0.02	$0.08	$0.05	($0.03)	($0.43)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	26.92M	28.36M	25.66M	33.57M	26.86M	33.22M	30.43M	29.38M	30.10M	24.15M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	30.45M	30.64M	30.63M	31.02M	28.45M	28.40M	26.58M	24.35M	23.27M
Normalized Net Operating Profit after Tax (NOPAT)	7.61	22	12	-15	14	9.08	-1.96	0.80	1.66	-1.15	-7.58
Normalized NOPAT Margin	8.92%	21.99%	14.49%	-17.24%	14.41%	9.23%	-2.32%	0.93%	1.99%	-1.30%	-9.19%
Pre Tax Income Margin	9.15%	22.41%	15.06%	-34.15%	25.48%	17.28%	0.57%	4.50%	6.31%	0.28%	-11.34%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	-1.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-1.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	1.71%	0.00%	0.00%	0.00%	54.35%	175.73%	178.21%	240.19%	6,516.67%	-2,848.88%

Financials Breakdown Chart

Key Financial Trends

Ibotta, Inc. (NYSE: IBTA) has reported quarterly results across 2023–2025 in the data you provided. Below is a concise, data-driven view of the last four years, focusing on tangible trends in revenue, margins, cash flow, and balance-sheet health. Bullets highlight key takeaways for retail investors.

Gross margins have remained robust, with Total Gross Profit as a share of Revenue typically around the high-70s to mid-80s percent range. For example, Q4 2025 shows a gross margin of about 78.6% (69.63M gross profit on 88.53M revenue), and Q3 2025 about 79.5% (66.12M on 83.26M).
Positive operating cash flow in multiple recent quarters, indicating core cash-generating capability. Notably, Q4 2025 net cash from continuing operating activities was about $27.8M, with Q3 2025 around $21.8M and Q2 2025 around $25.9M.
No long-term debt on the balance sheet (Long-Term Debt = 0), reducing interest costs and financial risk. The balance sheet shows liquidity alongside a sizable cash balance.
Solid liquidity, with cash and equivalents in the low hundreds of millions (e.g., around $223M at Q3 2025), and higher levels in early 2025, providing flexibility to fund operations and potential share repurchases or strategic initiatives.
Revenue generally remains substantial across periods and shows resilience around the mid-80s to high-80s millions in 2025, though Q4 2025 revenue declined to about $88.5M from Q4 2024’s $98.4M, signaling some near-term slack in top-line growth.
Operating expenses (SG&A, Marketing, and R&D) are sizable and represent a substantial portion of revenue (Total Operating Expenses around $71.3M on $88.5M revenue in Q4 2025), signaling ongoing investment that may pressure margin expansion in the near term.
Large quarterly share repurchases are a recurring financing activity, using substantial cash resources (examples include roughly $54.8M in Q4 2025, $70.4M in Q2 2025, $38.0M in Q3 2025, and $69.8M in Q1 2025). These actions can affect liquidity and per-share metrics, with mixed implications for investors.
Net income fluctuates from quarter to quarter; Q4 2025 shows a net loss attributable to common shareholders of about $1.0M, with basic and diluted EPS at -$0.03, signaling that profitability on a per-share basis is not yet consistent.
Retained earnings have been negative on multiple balance sheets (e.g., around -$139.9M to -$135.9M in recent quarters), indicating ongoing cumulative losses despite positive cash flows in certain periods.
Net change in cash and equivalents is often negative in quarters with heavy financing activity (e.g., Q2 2025 and Q4 2025 show notable negative net cash flow from financing activities and negative year-end cash movements), underscoring reliance on financing cash flows to balance liquidity during periods of large buybacks.

05/14/26 06:38 AM ETAI Generated. May Contain Errors.

Ibotta Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ibotta's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Ibotta's net income appears to be on an upward trend, with a most recent value of $3.58 million in 2025, falling from -$54.86 million in 2022. The previous period was $68.74 million in 2024. Check out Ibotta's forecast to explore projected trends and price targets.

Ibotta's total operating income in 2025 was -$841 thousand, based on the following breakdown:

Total Gross Profit: $271.33 million
Total Operating Expenses: $272.18 million

Over the last 3 years, Ibotta's total revenue changed from $210.70 million in 2022 to $342.39 million in 2025, a change of 62.5%.

Ibotta's total liabilities were at $238.26 million at the end of 2025, a 7.7% increase from 2024, and a 18.4% decrease since 2023.

In the past 2 years, Ibotta's cash and equivalents has ranged from $62.59 million in 2023 to $349.28 million in 2024, and is currently $186.61 million as of their latest financial filing in 2025.

Over the last 3 years, Ibotta's book value per share changed from 0.00 in 2022 to 10.82 in 2025, a change of 1,082.1%.

Related Companies

Financial statements for NYSE:IBTA last updated on 5/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ibotta (IBTA) Financials

Financials Breakdown Chart

Key Financial Trends

Ibotta Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ibotta (IBTA) Financials

Annual Income Statements for Ibotta

Quarterly Income Statements for Ibotta

Annual Cash Flow Statements for Ibotta

Quarterly Cash Flow Statements for Ibotta

Annual Balance Sheets for Ibotta

Quarterly Balance Sheets for Ibotta

Annual Metrics And Ratios for Ibotta

Quarterly Metrics And Ratios for Ibotta

Financials Breakdown Chart

Key Financial Trends

Ibotta Financials - Frequently Asked Questions

When does Ibotta's financial year end?

How has Ibotta's net income changed over the last 3 years?

What is Ibotta's operating income?

How has Ibotta's revenue changed over the last 3 years?

How much debt does Ibotta have?

How much cash does Ibotta have?

How has Ibotta's book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools